Kiniksa's 15min chart triggers Bollinger Bands Narrowing, Bearish Marubozu signal.
ByAinvest
Friday, Aug 22, 2025 2:02 pm ET2min read
KNSA--
Recent Price Movements
The stock gained 1.11% on August 21, 2025, rising from $33.21 to $33.58 [1]. During the last trading day, the stock fluctuated 2.37% from a day low at $32.90 to a day high of $33.68. The price has risen in 7 of the last 10 days and is up by 1.42% over the past two weeks. The volume fell on the last day by -18 thousand shares and in total, 322 thousand shares were bought and sold for approximately $10.80 million.
Analyst Sentiment
Shares of Kiniksa Pharmaceuticals International, plc (KNSA) have gained 15% over the past four weeks, closing at $33.38. Wall Street analysts believe that the stock could rally further, with a mean estimate of $42.29, indicating a potential upside of 26.7% [2]. The average price target ranges from a low of $32.00 to a high of $55.00, with a standard deviation of $8.96. Despite the variability in estimates, the consensus price target suggests a strong bullish outlook.
Technical Indicators and Market Trends
The Bollinger Bands narrowing and the Bearish Marubozu observed on August 22, 2025, at 14:00, indicate a decrease in price volatility and a bearish trend. This pattern suggests that sellers are currently dominant in the market. The 3-month Moving Average Convergence Divergence (MACD) also indicates a sell signal, while the short and long-term Moving Averages provide buy signals, suggesting a mixed signal environment [1].
Trading Expectations
For the upcoming trading day on Friday, August 23, 2025, Kiniksa Pharmaceuticals International, plc (KNSA) is expected to open at $33.39, with a possible trading interval of +/-$1.06 (+/-3.22%) up or down from the last closing price. The stock is closer to the resistance at $33.65 than the support at $30.37, making the intra-day trading risk/reward unattractive [1].
Conclusion
Kiniksa Pharmaceuticals International, plc (KNSA) has shown mixed signals with recent price movements and analyst sentiments. While the Bollinger Bands narrowing and Bearish Marubozu indicate a bearish trend, the consensus price target and earnings estimate revisions suggest a potential upside. Investors should monitor the stock closely and consider the mixed signals before making investment decisions.
References
[1] https://stockinvest.us/stock/KNSA
[2] https://www.nasdaq.com/articles/wall-street-analysts-believe-kiniksa-pharmaceuticals-international-plc-knsa-could-rally
Kiniksa's 15-minute chart has exhibited a notable pattern, with Bollinger Bands Narrowing and a Bearish Marubozu observed on August 22, 2025 at 14:00. This phenomenon suggests a decrease in the magnitude of stock price fluctuations, indicating that sellers are currently exerting control over the market. Furthermore, this trend is likely to persist, as bearish momentum continues to dominate the market dynamics.
Kiniksa Pharmaceuticals International, plc (KNSA) has been a subject of interest for investors due to its recent price movements and analyst sentiments. On August 22, 2025, the stock exhibited a notable pattern with Bollinger Bands narrowing and a Bearish Marubozu observed at 14:00. This phenomenon suggests a decrease in stock price fluctuations, indicating that sellers are currently exerting control over the market. The trend is likely to persist, as bearish momentum continues to dominate market dynamics.Recent Price Movements
The stock gained 1.11% on August 21, 2025, rising from $33.21 to $33.58 [1]. During the last trading day, the stock fluctuated 2.37% from a day low at $32.90 to a day high of $33.68. The price has risen in 7 of the last 10 days and is up by 1.42% over the past two weeks. The volume fell on the last day by -18 thousand shares and in total, 322 thousand shares were bought and sold for approximately $10.80 million.
Analyst Sentiment
Shares of Kiniksa Pharmaceuticals International, plc (KNSA) have gained 15% over the past four weeks, closing at $33.38. Wall Street analysts believe that the stock could rally further, with a mean estimate of $42.29, indicating a potential upside of 26.7% [2]. The average price target ranges from a low of $32.00 to a high of $55.00, with a standard deviation of $8.96. Despite the variability in estimates, the consensus price target suggests a strong bullish outlook.
Technical Indicators and Market Trends
The Bollinger Bands narrowing and the Bearish Marubozu observed on August 22, 2025, at 14:00, indicate a decrease in price volatility and a bearish trend. This pattern suggests that sellers are currently dominant in the market. The 3-month Moving Average Convergence Divergence (MACD) also indicates a sell signal, while the short and long-term Moving Averages provide buy signals, suggesting a mixed signal environment [1].
Trading Expectations
For the upcoming trading day on Friday, August 23, 2025, Kiniksa Pharmaceuticals International, plc (KNSA) is expected to open at $33.39, with a possible trading interval of +/-$1.06 (+/-3.22%) up or down from the last closing price. The stock is closer to the resistance at $33.65 than the support at $30.37, making the intra-day trading risk/reward unattractive [1].
Conclusion
Kiniksa Pharmaceuticals International, plc (KNSA) has shown mixed signals with recent price movements and analyst sentiments. While the Bollinger Bands narrowing and Bearish Marubozu indicate a bearish trend, the consensus price target and earnings estimate revisions suggest a potential upside. Investors should monitor the stock closely and consider the mixed signals before making investment decisions.
References
[1] https://stockinvest.us/stock/KNSA
[2] https://www.nasdaq.com/articles/wall-street-analysts-believe-kiniksa-pharmaceuticals-international-plc-knsa-could-rally
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet